Our newest Smart Infusion location in Onalaska is now open!
Infusion therapy is the administration of medication in a controlled manner via IV or injection for effective results. This type of therapy can be used to treat a wide range of illnesses in a safe and accurate manner.
At Smart Infusion Therapy Services in Eau Claire, Wausau, Madison and Onalaska, Wisconsin, our highly trained staff is dedicated to providing patients with the best possible care. We offer a wide range of infusion therapies tailored to the individual needs of each patient. We offer infusion therapy for:
Our team is committed to working closely with your patients to ensure that their treatment is both safe and effective.
In addition to providing high-quality infusion treatment, our team is dedicated to making sure that your patients are comfortable and stress-free. We take the time to understand each patient’s individual needs, answer questions and address any concerns they may have. Our goal is to provide them with an environment that allows them to relax and focus on getting better.
If you're ready to take the first step to give your patients a healthier life, refer a patient with Smart Infusion today.
Actemra (tocilizumab) is a medication prescribed for treating active cases of moderate-to-severe adult rheumatoid arthritis. Actemra works by preventing cells from producing inflammatory molecules via blocking IL-6 which helps reduce signs and symptoms such as pain, swelling, fatigue as well as slow disease activity over time.
Aralast (Alpha 1 Proteinase inhibitor) is a liquid medication used to treat alpha-1 antitrypsin deficiency. It works by replacing the missing or low levels of AAT in the body and thereby helping protect against lung tissue damage and reduce COPD exacerbation.
Avsola (infliximab-axxq, mavrilimumab remicade biosimilar) is a medication that helps reduce signs and symptoms of active rheumatoid arthritis and psoriatic arthritis in adults when taken alongside other medications for the same condition. Avsola prevents cells from producing inflammatory molecules, helping to slow down disease progression while also relieving pain and swelling associated with RA and PsA.
Avsola is also a biologic agent indicated as maintenance therapy in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, loss of response, or intolerance to immunomodulators or corticosteroids.
Benlysta is an IV infusion therapy approved for the treatment of adult and pediatric patients aged 5 years and older with active lupus nephritis or SLE. It blocks B cell production which is responsible for the inflammation and symptoms of SLE.
Cimzia (certolizumab pegol) is a subcutaneous injection prescribed for the treatment of rheumatoid and psoriatic arthritis. It works by blocking certain proteins that cause the disease and helps reduce the symptoms of joint pain, swelling, stiffness, and skin manifestations experienced with arthritis.
Cimzia is also prescribed for the treatment of adult patients with moderate to severe active Crohn's Disease.
Cinqair is an IV infusion medication. Cinqair reduces the number of eosinophils, helping to lessen asthma symptoms.
Entyvio is an IV infusion therapy used to treat adult patients with active moderate to severe ulcerative colitis or Crohn's disease.
Fasenra (benralizumab) is a therapy that can be used as a maintenance treatment for patients aged 12 and above who suffer from severe eosinophilic asthma.
Glassia is a liquid medication that helps treat alpha 1 antitrypsin (AAT) deficiency. It works by replacing the missing or low levels of AAT in the body and thereby helping protect against lung tissue damage.
Ilumya is a given as a subcutaneous injection for adults. Ilumya is dosed 4 times a year after 2 initial injections.
Inflectra (infliximab-dyyb, biosimilar of Remicade) is a biologic therapy that can help reduce inflammation caused by rheumatoid and psoriatic arthritis, thus relieving pain, stiffness, swelling, and skin manifestations associated with these conditions while also slowing their progression over time.
Inflectra is also a biosimilar agent approved for the treatment of adults with moderately to severely active ulcerative colitis and psoriatic arthritis.
Krystexxa (pegloticase) is an intravenous medication designed to treat severe cases of tophaceous gout in adults that have failed other treatments. This medication works by breaking down uric acid crystals that form in the joints and cause inflammation, pain, and swelling associated with gout. Krystexxa is administered every two weeks or as prescribed by your doctor based on your condition and response to treatment.
Leqvio is an injection medication specifically designed to help reduce levels of "bad" cholesterol (low-density lipoprotein, or LDL-C) in adults. This medication works by decreasing the amount of cholesterol absorbed from the intestines, thus helping reduce levels of unhealthy cholesterol in the body and improving heart health.
Nucala is an injectable biologic treatment used to help patients with severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis (EGPA), hypereosinophilic syndrome, and chronic rhinosinusitis with nasal polyps.
Orencia (abatacept) is a medication used for treating adult patients suffering from moderate-to-severe RA or PsA. It reduces inflammation associated with RA and PsA, making it easier for patients to move more freely without feeling much discomfort due to joint stiffening or swelling. This drug works by preventing B-cells from producing inflammatory molecules.
Prolastin-C (Alpha 1 Proteinase inhibitor) is an immunoglobulin product that helps treat alpha-1 antitrypsin deficiency. It works by replacing the missing or low levels of AAT in the body.
Remicade (infliximab) is an intravenous medication prescribed to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, and other autoimmune diseases. This drug works by blocking proteins that are associated with inflammation, helping to relieve symptoms such as joint pain and stiffness while also slowing down disease progression.
Remicade is also approved for the treatment of adults and pediatric patients aged 6 years and older with moderately to severely active Crohn’s disease.
Renflexis (infliximab-adba, Remicade biosimilar) is an intravenous therapy used for managing moderate-to-severe adult RA and PsA. It prevents the immune system from attacking joint tissues, thus helping bring down inflammation levels, pain, stiffness, and skin manifestations.
Renflexis is also used for the induction and maintenance of clinical remission in adult and pediatric patients 6 years of age and older with moderate to severe ulcerative colitis
Rituxan (rituximab) is a biologic therapy employed in treating moderate-to-severe adult cases of rheumatoid arthritis who have failed previous therapies. It works by inhibiting certain white blood cells which help lower levels of inflammations leading up reduced joint swelling and stiffness. This drug works by preventing B-cells from producing inflammatory molecules.
Ruxience (tocilizumab-aqqg biosimilar of rituximab) is an intravenous medication used in the treatment of active rheumatoid arthritis in adults. It helps reduce signs and symptoms of the disease, such as pain and swelling, while also slowing its progression. This drug works by preventing B-cells from producing inflammatory molecules.
Sandostatin is a long-term maintenance therapy in patients with acromegaly who have had inadequate response to surgery and/or radiotherapy or for whom surgery and/or radiotherapy is not an option (the goal of treatment in acromegaly is to reduce GH and IGF-1 levels to normal)
Saphnelo is an IV infusion medication used to treat adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE). It blocks interferons which cause inflammation and symptoms of SLE.
Simponi Aria (golimumab) is an intravenous medication for treating moderately-to-severely active RA and PsA in adult patients. It prevents the immune system from attacking joint tissues, thus helping bring down inflammation levels, pain, stiffness, and skin manifestations.
Simponi Aria is also used to treat moderate-to-severe cases of ankylosing spondylitis in adult patients.
Skyrizi IV is an IV infusion medication used to treat adult patients with active Crohn’s disease and moderate to severe active ulcerative colitis.
Soliris works by interrupting the antibody-mediated attack on acetylcholine receptors in the muscles. The medication needs to be given every two weeks in order to maintain its effectiveness, but it is proven to reduce symptoms associated with MG.
Stelara SQ and Stelara IV are both biologics indicated for the treatment of adult patients with moderately to severely active Crohn’s Disease.
Stelara SQ ais also used for the treatment of adult patients with moderately to severely active ulcerative colitis.
Tepezza is an FDA-approved treatment for thyroid eye disease that has been proven to reduce inflammation and improve vision.
Tezspire is a prohuman monoclonal antibody (mAb) designed to treat patients ages 12 years and up for severe asthma symptoms.
Truxima (rituximab-abbs biosimilar) is a therapy used to treat moderate to severe cases of rheumatoid arthritis in adults who have not responded adequately to other treatments for the same conditions. This drug works by preventing B-cells from producing inflammatory molecules.
Tysabriis an IV infusion therapy approved for the treatment of adult patients with relapsing forms of multiple sclerosis.
Ultomiris works by binding to the complement protein C5 to block its activation and remove it from the bloodstream. It is administered every one to two months, providing a more managed approach to controlling myasthenia gravis symptoms.
Vyepti is an IV infusion therapy for chronic migraines. It reduces the frequency and intensity of headaches, allowing those suffering from chronic migraines to lead a more productive life. Vyepti works by targeting and blocking hormones and proteins that triggers migraine headaches.
Vyvgart works by blocking certain receptors from binding with harmful AChR antibodies which are responsible for triggering the symptoms of myasthenia gravis, resulting in a reduction of symptoms.
Xolair is used to treat asthma and chronic hives or chronic idiopathic urticaria (CIU) in patients as young as six years of age. Patients prescribed Xolair are usually those who have unsuccessfully tried other treatments, such as inhalers or corticosteroids.
Zemaira (Alpha 1 Proteinase inhibitor) is a high-quality liquid medication designed to help treat alpha-1 antitrypsin deficiency. It works by replacing the missing or low levels of AAT in the body and thereby helping protect against lung tissue damage.
Yes, to receive infusion therapy, you will need an order from your primary care doctor or specialist.
If you’d like to get started with Smart Infusion but don’t yet have an order from your doctor, contact our team. We’ll help you and your existing care team coordinate a referral to ensure that you can start receiving the infusion therapy needed for your condition.
Yes, we have private rooms available for infusion therapy treatments. These rooms provide a comfortable and relaxing environment for you to receive your treatment in privacy. Our facility also has comfortable seating, WiFi, Netflix, snacks, and beverages.
Smart Infusion makes it simple to get started. Just fill out our simple online form to begin.